
Pharma Weekly Updates in a Quick, 2-Minute Read.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 161 | Founded | 3 years ago | Last Issue | 47 hours ago |
| Active | |||||

🤝 Ipsen will buy Kartos Therapeutics, Inc. for up to $1.75B and Memo Therapeutics AG for over €700M to strengthen its rare disease pipeline.
💰 Abivax raised $920M in the U.S. after reassuring obefazimod data, strengthening its balance sh...
🤝 AbbVie will acquire Apogee Therapeutics for $10.9B, adding immunology assets for atopic dermatitis and asthma.
👁️ Ollin Biosciences raised $330M Series B to move bispecific retinal antibody OLN324 into global Phase 3 trials.
Thanks fo...
🤝 Biogen will acquire RayThera for up to $1B, adding preclinical and early immunology small molecules.
💉 Moderna’s mRNA flu vaccine won unanimous FDA advisory panel support for adults aged 50 and older.
Thanks for reading 🔬 Latest Phar...
This edition is sponsored by AzurBio - supporting biotech and pharma companies looking to enter, understand, and grow in the European market.
🤝 GSK will acquire Nuvalent, Inc. for $10.6B, gaining drug programs for certain types of...
This edition is sponsored by AzurBio - supporting biotech and pharma companies looking to enter, understand, and grow in the European market.
🤝 Servier will acquire Edgewise Therapeutics’ muscular dystrophy business for up to $...
Subscribers, engagement, traffic and sponsorship for \ud83d\udd2c Latest Pharma Industry Updates.
| Subscribers | Engagement | 70 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #239 |
The writers behind this newsletter.
Pharma Senior Market Analyst providing weekly updates about the Life science industry.
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.